ArticleInternational journal of women's health2025
Analysis and Prediction Study on the Disease Burden of Inflammatory Bowel Disease Among Chinese Women of the Reproductive Age.
Article in International journal of women's health, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Purpose: To analyze the disease burden of inflammatory bowel disease (IBD) among Chinese women of reproductive age (WRA) from 1990 to 2021, as well as the projected trends through 2035. Patients and Methods: A segmented regression analysis was carried out to assess the temporal trend of the disease burden. Additionally, the age period cohort (APC) model was applied to explore the impact of each factor on IBD. Based on the APC model, a Bayesian approach was used to predict the disease burden during the period from 2022 to 2035. Results: In 2021, the number of Chinese WRA with IBD was approximately 38,701, with a standardized prevalence rate of 9.47 per 100,000, both of which were lower than the global averages. From 1990 to 2021, the standardized prevalence rate of IBD among Chinese WRA showed an upward trend with an average annual percentage change (AAPC) of 1.53%, while the standardized DALY rate of IBD showed a downward trend with an AAPC of -3.36%. The APC model showed that the longitudinal age curves of IBD prevalence and DALY rate increased with age. Over time, the risk of IBD among Chinese WRA showed a trend of first increasing and then decreasing, while the risk of DALY showed an overall downward trend with the passage of time. Results regarding birth cohorts indicated that the risk of IBD among Chinese WRA gradually increased with the advancement in birth cohorts, whereas the risk of DALY gradually decreased. Conclusion: Age, period, and birth cohort have significant impacts on the disease burden of IBD among WRA. Going forward, it remains necessary to strengthen attention to the population of WRA with IBD and formulate appropriate health measures and strategies to prevent and manage the prevalence of IBD among WRA.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.